Bioxcel Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Bioxcel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Bioxcel Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Bioxcel Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $86k | 29k | 2.95 |
| 2023-09-30 | $69k | 27k | 2.53 |
| 2023-06-30 | $188k | 28k | 6.66 |
| 2023-03-31 | $625k | 34k | 18.66 |
| 2022-12-31 | $663k | 31k | 21.49 |
| 2022-09-30 | $359k | 30k | 11.83 |
| 2022-06-30 | $376k | 29k | 13.19 |
| 2022-03-31 | $381k | 18k | 20.93 |
| 2021-12-31 | $327k | 16k | 20.31 |
| 2021-09-30 | $465k | 15k | 30.37 |
| 2021-06-30 | $421k | 15k | 29.04 |
| 2021-03-31 | $586k | 14k | 43.17 |
| 2020-12-31 | $704k | 15k | 46.22 |
| 2020-09-30 | $599k | 14k | 43.35 |
| 2020-06-30 | $820k | 16k | 53.03 |